Creating a Pathway for Disease-Free Cancer Survivors to Decrease Long-term Opioid Use
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pain
- Sponsor
- Virginia Commonwealth University
- Enrollment
- 18
- Locations
- 1
- Primary Endpoint
- Recruitment yield number of participants enrolled
- Status
- Suspended
- Last Updated
- 8 months ago
Overview
Brief Summary
This is a feasibility pilot trial assessing a behavioral intervention for chronic pain among disease-free cancer survivors to decrease long-term opioid dependence.
Detailed Description
To assess the feasibility and acceptability of implementing brief Acceptance and Commitment Therapy for chronic pain (ACT-CP) in a Survivorship clinic.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of cancer of any type, currently in remission, having completed active primary therapy. Patients on oral adjuvant hormone therapy will still be eligible.
- •Completed active therapy must have been curative in intent (for example stage IV cancer patients such as head and neck cancer patients treated with curative intent are eligible).
- •Self-reported cancer pain for \>= 3 months
- •Opioid use \>= 5MME/day (morphine milligram equivalents) as prescribed by physician for cancer-related pain for at least 6 months beyond completion of their cancer treatment
- •VCUHealth system patient
Exclusion Criteria
- •History of opioid use prior to cancer diagnosis
- •Anyone with prior history of substance use disorder or currently enrolled in a methadone program
- •Anyone with schizophrenia or bipolar disorder
- •Current utilization of psychotherapy services for pain, depression, anxiety, and/or PTSD
- •Cognitive concerns that would prevent meaningful engagement in treatment
- •Inability to converse in English
- •Lack of working telephone and Internet connection (must have at least one or the other)
- •Anyone found to have progression of cancer
- •Anyone diagnosed with cancer recurrence or new cancer during their study period
- •Documented diagnosis of or positive screen for current substance use disorder (score \>5 on the Drug Abuse Screening Test-10 \[DAST-10\])
Outcomes
Primary Outcomes
Recruitment yield number of participants enrolled
Time Frame: 12 Months
Study feasibility will be assessed by recruitment yield, i.e., tracking the number of participants who initiated treatment.
Recruitment yield of participants consented
Time Frame: 12 Months
Study feasibility will be assessed by tracking the number of participants that consent to enroll in the trial.
Session Attendance
Time Frame: 6 Weeks
Study feasibility will be assessed by tracking the number of participants attend each intervention session over the course of the 6-week intervention period.
Participant Satisfaction
Time Frame: 6 Weeks
Study acceptability will be assessed by administering a post-intervention satisfaction survey which asks about satisfaction with the program including perceived efficacy and suggestions for improvement.
Recruitment yield of participants contacted
Time Frame: 12 Months
Study feasibility will be assessed by tracking the number of patients contacted
Secondary Outcomes
- Opioid Use Frequency(6 Weeks)
- Pain Intensity(6 Weeks)
- Pain interference(6 Weeks)
- Opioid Refill Frequency(6 Weeks)